GO
Loading...

Enter multiple symbols separated by commas

Innovation Science

More

  • Double dose of virus concern Monday, 6 Oct 2014 | 2:04 PM ET
    Double dose of virus concern

    Dr. Devi Nampiaparampil, NYU School of Medicine, discusses vaccines to combat Ebola and addresses growing concerns over enterovirus D-68.

  • Ebola patient gets Chimerix's drug Monday, 6 Oct 2014 | 2:00 PM ET
    Ebola patient gets Chimerix's drug

    CNBC's Meg Tirrell reports the Dallas Ebola patient, Thomas Eric Duncan, is getting an experimental drug made by Chimerix, and that company's stock is spiking.

  • Nebraska Medical to treat Ashoka Mukpo: Report Friday, 3 Oct 2014 | 2:54 PM ET
    Nebraska Medical to treat Ashoka Mukpo: Report

    The Nebraska Medical Center will receive Ashoka Mukpo, the NBC News photographer who was infected with the Ebola Virus, reports CNBC's Meg Tirrell.

  • Gov. Jindal: Stop flights from Ebola stricken countries

    CNBC's Meg Tirrell reports Louisiana Governor Bobby Jindal is calling on President Obama to shut down flights from West Africa. Tirrell also provides the latest numbers on the infected.

  • CDC confident of Ebola containment Thursday, 2 Oct 2014 | 2:26 PM ET
    CDC confident of Ebola containment

    CNBC's Meg Tirrell reports the family members of the man being treated for the Ebola virus have been ordered to stay home until October 19th.

  • Danger of Ebola spreading? Wednesday, 1 Oct 2014 | 3:18 PM ET
    Danger of Ebola spreading?

    Discussing Ebola fear and the dangers of the virus spreading, with Dr. Leigh Vinocur, American College of Emergency Physicians.

  • Texas DSHS confident of Ebola containment Wednesday, 1 Oct 2014 | 2:10 PM ET
    Texas DSHS confident of Ebola containment

    CNBC's Meg Tirrell reports the person with the first confirmed case of Ebola in the U.S. is in serious but stable condition, and all of his contacts are being monitored.

  • Positive data from Roche breast cancer drug Monday, 29 Sep 2014 | 6:25 AM ET
    Positive data from Roche breast cancer drug

    A breast cancer drug from Roche known as Perjeta helped patients live nearly 16 months longer compared with Herceptin and chemotherapy alone. CNBC's Meg Tirrell provides insight to the data.

  • Google Science Fair winners Wednesday, 24 Sep 2014 | 11:22 AM ET
    Google Science Fair winners

    Three teenagers from Ireland took home the top prize in Google's Science Fair competition, reports CNBC's Kaya Tausche.

  • India triumphs in maiden Mars mission Wednesday, 24 Sep 2014 | 12:16 AM ET
    A father and his son look at information about planet Mars on a poster put up at the Nehru Planetarium as a special preview on India's Mars Orbiter Mission, in Bangalore.

    India's low-cost mission to Mars successfully entered the orbit, crowning India as the first country to complete the trip at its maiden attempt.

  • Race to treat ebola Tuesday, 23 Sep 2014 | 5:47 PM ET
    Race to treat ebola

    The FDA authorized Tekmira's ebola drug for potential use through an expanded access program. CNBC's Meg Tirrell reports which other companies are working on drugs to fight ebola.

  • New Ebola estimate Tuesday, 23 Sep 2014 | 10:57 AM ET
    New Ebola estimate

    CNBC's Meg Tirell reports the latest projections on the Ebola virus.

  • Ebola could infect 1.4 million by January Tuesday, 23 Sep 2014 | 10:41 AM ET

    The world's attention may have shifted to U.S. airstrikes on Syria, but West Africa continues to be ravaged by the worst outbreak of Ebola.

  • China drives world carbon emissions to record high Sunday, 21 Sep 2014 | 1:23 PM ET

    World carbon dioxide emissions will hit a record high this year, driven by China's growth and keeping the world far off track from the deep cuts needed to limit climate change, a study said on Sunday.

  • ReWalk 'life changing' for wounded U.S. Marine Captain Wednesday, 17 Sep 2014 | 1:19 PM ET
    ReWalk 'life changing' for wounded U.S. Marine Captain

    Derek Herrera, wounded U.S. Marine Captain, discusses how ReWalk's wearable robotic exoskeleton device has impacted his life for the better and demonstrates the device.

  • FDA creates new category for exoskeletons Wednesday, 17 Sep 2014 | 1:16 PM ET
    FDA creates new category for exoskeletons

    ReWalk CEO Larry Jasinski discusses just how big the market for wearable robotic exoskeleton devices could get.

  • Why it's so hard to call the end of a drought Tuesday, 16 Sep 2014 | 1:58 PM ET
    Drought

    Unlike a hurricane, tornado or snowstorm, the ends and beginning of droughts are very hard to predict.

  • Pharma in focus: Ebola & Enterovirus D68 Tuesday, 16 Sep 2014 | 1:31 PM ET
    Pharma in focus: Ebola & Enterovirus D68

    CNBC's Meg Tirrell runs down today's top health care headlines, including a major move by President Obama to fight the Ebola virus and the latest on Enterovirus D68.

  • Avanir up on Alzheimer's trial Monday, 15 Sep 2014 | 1:03 PM ET
    Avanir up on Alzheimer's trial

    Avanir Pharma is up more than 60 percent, after the company said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo. CNBC's Meg Tirrell speaks to the company's CEO Keith Katkin.

  • 'I am a science geek!': 'Big Bang Theory' actress Thursday, 11 Sep 2014 | 1:17 PM ET
    Mayim Bialik

    "Big Bang" actress Mayim Bialik is a self-proclaimed science geek (she has a Ph.D.) and wants to get kids excited about math and science.